Tuesday 6th October 2020


FIPO – Functional Indirect posterior Onlays – Concept Part 1

GC in collaboration with
Dr Riaz Yar and Nik Sethi 


Septodont left banner

Article: Volume 46 Number 3 Page 280 - March 2019

Prev    Article P280    Next  Read article

  Dent Update 2019; 46: 280-284

Periodontics:  Amlodipine-Induced Gingival Overgrowth in the Peri-Implant Region: A Review and Case Report

CPD:  CPD  0:24   (closed)      Self assess

Feedback:  0 comments, 0 ratings


Abstract: Gingival overgrowth is a known side-effect of the antihypertensive drug amlodipine, but the risk of mucosal overgrowth around dental implants has been less well documented. This article discusses the role of calcium channel blockers in drug-induced mucosal overgrowth around dental implants and describes the preventive and surgical management of the case.

Clinical relevance: The report describes the management of a patient with an implant-supported restoration who presented with peri-implantitis and drug-induced mucosal overgrowth. The review discusses how amlodipine and other medications, commonly associated with drug-induced gingival overgrowth, impact on the management of implant patients.

Author notes: Neil MacBeth, BDS, MSc(Cons), MFGDP(UK), MFDS, MGDS FDS(Rest), FFGDP, Consultant in Restorative Dentistry, Centre for Restorative Dentistry, Defence Primary Health Care (Dental), Evelyn Woods Road, Aldershot GU11 2LS, email: neil.macbeth1@btinternet.com, Stephen Sterlitz, DDS, MS, DABGD, FAGD, Clinical Assistant Professor, University of Michigan School of Dentistry, 1011 N University, Ann Arbor, MI 48109, USA and Graeme Bryce Royal Navy, BDS, MSc(Endo), MRD, MEndo, RCS(Edin), FDS(Rest), Consultant in Restorative Dentistry, Defence Primary Health Care (Dental), Evelyn Woods Road, Aldershot, GU11 2LS, UK.

Objective: To provide guidance on the successful management of an implant affected by both mucosal overgrowth and peri-implantitis using both surgical and non-surgical techniques.

Denplan Bottom